HEADER TRANSPORT PROTEIN 04-AUG-22 8DYP TITLE CRYSTAL STRUCTURE OF HUMAN CYSTINE TRANSPORTER CYSTINOSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTINOSIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: NANOBODY P10; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTNS; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LYSOSOMAL TRANSPORTER, PROTON-COUPLED TRANSPORTER, CYSTINE KEYWDS 2 TRANSPORTER, CYSTINOSIS, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.GUO,L.FENG REVDAT 2 18-OCT-23 8DYP 1 REMARK REVDAT 1 16-NOV-22 8DYP 0 JRNL AUTH X.GUO,P.SCHMIEGE,T.E.ASSAFA,R.WANG,Y.XU,L.DONNELLY,M.FINE, JRNL AUTH 2 X.NI,J.JIANG,G.MILLHAUSER,L.FENG,X.LI JRNL TITL STRUCTURE AND MECHANISM OF HUMAN CYSTINE EXPORTER JRNL TITL 2 CYSTINOSIN. JRNL REF CELL V. 185 3739 2022 JRNL REFN ISSN 1097-4172 JRNL PMID 36113465 JRNL DOI 10.1016/J.CELL.2022.08.020 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 9779 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.272 REMARK 3 R VALUE (WORKING SET) : 0.270 REMARK 3 FREE R VALUE : 0.302 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.970 REMARK 3 FREE R VALUE TEST SET COUNT : 975 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.1900 - 6.5000 1.00 1383 154 0.2562 0.2875 REMARK 3 2 6.5000 - 5.1600 1.00 1309 145 0.2896 0.3147 REMARK 3 3 5.1600 - 4.5100 0.99 1270 140 0.2392 0.2500 REMARK 3 4 4.5100 - 4.1000 1.00 1277 141 0.2521 0.2771 REMARK 3 5 4.1000 - 3.8000 1.00 1252 139 0.2865 0.3263 REMARK 3 6 3.8000 - 3.5800 0.93 1170 130 0.3289 0.3989 REMARK 3 7 3.5800 - 3.4000 0.90 1143 126 0.3324 0.4118 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.029 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 105.7 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 100.5 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3460 REMARK 3 ANGLE : 0.724 4720 REMARK 3 CHIRALITY : 0.048 543 REMARK 3 PLANARITY : 0.006 581 REMARK 3 DIHEDRAL : 14.928 1167 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DYP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000261419. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-AUG-18; 21-JUL-18; 03-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100; 100; 100 REMARK 200 PH : 6.0-6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y; Y REMARK 200 RADIATION SOURCE : APS; APS; APS REMARK 200 BEAMLINE : 23-ID-B; 24-ID-E; 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M; M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9794; 0.9794; 0.9794 REMARK 200 MONOCHROMATOR : NULL; NULL; NULL REMARK 200 OPTICS : NULL; NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL; PIXEL; PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M; DECTRIS REMARK 200 EIGER X 16M; DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9815 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.400 REMARK 200 RESOLUTION RANGE LOW (A) : 40.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 14.90 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.9 REMARK 200 DATA REDUNDANCY IN SHELL : 8.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.690 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH; SINGLE REMARK 200 WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3P0G, 4X5N REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG400, 80MM LI2SO4, AND 50MM MES REMARK 280 PH6.0, PH 6.5, LIPIDIC CUBIC PHASE, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.63500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 97.32000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.63500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 97.32000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 104 REMARK 465 HIS A 105 REMARK 465 SER A 106 REMARK 465 ALA A 107 REMARK 465 GLN A 108 REMARK 465 THR A 109 REMARK 465 ALA B 26 REMARK 465 SER B 27 REMARK 465 GLY B 28 REMARK 465 SER B 29 REMARK 465 TYR B 103 REMARK 465 GLY B 104 REMARK 465 ASP B 105 REMARK 465 ARG B 106 REMARK 465 GLN B 107 REMARK 465 ARG B 108 REMARK 465 TYR B 109 REMARK 465 GLY B 110 REMARK 465 HIS B 111 REMARK 465 LEU B 112 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 47 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 54 CG CD1 CD2 REMARK 470 GLU A 59 CG CD OE1 OE2 REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 ARG A 151 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 153 CG CD CE NZ REMARK 470 GLU A 295 CG CD OE1 OE2 REMARK 470 TRP A 326 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 326 CZ3 CH2 REMARK 470 LYS B 33 CG CD CE NZ REMARK 470 LYS B 45 CG CD CE NZ REMARK 470 LYS B 77 CG CD CE NZ REMARK 470 TYR B 81 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 100 CG OD1 OD2 REMARK 470 ASP B 102 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 200 35.73 -86.26 REMARK 500 VAL B 50 -78.55 -115.93 REMARK 500 REMARK 500 REMARK: NULL DBREF 8DYP A 25 356 UNP O60931 CTNS_HUMAN 25 356 DBREF 8DYP B 8 125 PDB 8DYP 8DYP 8 125 SEQADV 8DYP ALA A 36 UNP O60931 ASN 36 CONFLICT SEQADV 8DYP ALA A 41 UNP O60931 ASN 41 CONFLICT SEQADV 8DYP ALA A 51 UNP O60931 ASN 51 CONFLICT SEQADV 8DYP ALA A 66 UNP O60931 ASN 66 CONFLICT SEQADV 8DYP ALA A 84 UNP O60931 ASN 84 CONFLICT SEQADV 8DYP ALA A 104 UNP O60931 ASN 104 CONFLICT SEQADV 8DYP ALA A 107 UNP O60931 ASN 107 CONFLICT SEQADV 8DYP ILE A 260 UNP O60931 THR 260 VARIANT SEQADV 8DYP ALA A 301 UNP O60931 ASN 301 CONFLICT SEQRES 1 A 332 SER LEU THR VAL PRO PRO VAL VAL LYS LEU GLU ALA GLY SEQRES 2 A 332 SER SER THR ALA VAL SER LEU THR LEU ARG PRO PRO LEU SEQRES 3 A 332 ALA ALA THR LEU VAL ILE THR PHE GLU ILE THR PHE ARG SEQRES 4 A 332 SER LYS ALA ILE THR ILE LEU GLU LEU PRO ASP GLU VAL SEQRES 5 A 332 VAL VAL PRO PRO GLY VAL THR ALA SER SER PHE GLN VAL SEQRES 6 A 332 THR SER GLN ASN VAL GLY GLN LEU THR VAL TYR LEU HIS SEQRES 7 A 332 GLY ALA HIS SER ALA GLN THR GLY PRO ARG ILE ARG PHE SEQRES 8 A 332 LEU VAL ILE ARG SER SER ALA ILE SER ILE ILE ASN GLN SEQRES 9 A 332 VAL ILE GLY TRP ILE TYR PHE VAL ALA TRP SER ILE SER SEQRES 10 A 332 PHE TYR PRO GLN VAL ILE MET ASN TRP ARG ARG LYS SER SEQRES 11 A 332 VAL ILE GLY LEU SER PHE ASP PHE VAL ALA LEU ASN LEU SEQRES 12 A 332 THR GLY PHE VAL ALA TYR SER VAL PHE ASN ILE GLY LEU SEQRES 13 A 332 LEU TRP VAL PRO TYR ILE LYS GLU GLN PHE LEU LEU LYS SEQRES 14 A 332 TYR PRO ASN GLY VAL ASN PRO VAL ASN SER ASN ASP VAL SEQRES 15 A 332 PHE PHE SER LEU HIS ALA VAL VAL LEU THR LEU ILE ILE SEQRES 16 A 332 ILE VAL GLN CYS CYS LEU TYR GLU ARG GLY GLY GLN ARG SEQRES 17 A 332 VAL SER TRP PRO ALA ILE GLY PHE LEU VAL LEU ALA TRP SEQRES 18 A 332 LEU PHE ALA PHE VAL THR MET ILE VAL ALA ALA VAL GLY SEQRES 19 A 332 VAL ILE THR TRP LEU GLN PHE LEU PHE CYS PHE SER TYR SEQRES 20 A 332 ILE LYS LEU ALA VAL THR LEU VAL LYS TYR PHE PRO GLN SEQRES 21 A 332 ALA TYR MET ASN PHE TYR TYR LYS SER THR GLU GLY TRP SEQRES 22 A 332 SER ILE GLY ALA VAL LEU LEU ASP PHE THR GLY GLY SER SEQRES 23 A 332 PHE SER LEU LEU GLN MET PHE LEU GLN SER TYR ASN ASN SEQRES 24 A 332 ASP GLN TRP THR LEU ILE PHE GLY ASP PRO THR LYS PHE SEQRES 25 A 332 GLY LEU GLY VAL PHE SER ILE VAL PHE ASP VAL VAL PHE SEQRES 26 A 332 PHE ILE GLN HIS PHE CYS LEU SEQRES 1 B 118 GLU SER GLY GLY GLY LEU VAL GLN ALA GLY GLY SER LEU SEQRES 2 B 118 ARG LEU SER CYS ALA ALA SER GLY SER ILE SER PRO LYS SEQRES 3 B 118 ASN TRP MET GLY TRP TYR ARG GLN ALA PRO GLY LYS GLU SEQRES 4 B 118 ARG GLU PHE VAL ALA THR ILE ASP TYR GLY ALA ASN THR SEQRES 5 B 118 ASN TYR ALA ASP SER VAL LYS GLY ARG PHE THR ILE SER SEQRES 6 B 118 ARG ASP ASN ALA LYS ASN THR VAL TYR LEU GLN MET ASN SEQRES 7 B 118 SER LEU LYS PRO GLU ASP THR ALA VAL TYR TYR CYS ALA SEQRES 8 B 118 ALA ASP TYR ASP TYR GLY ASP ARG GLN ARG TYR GLY HIS SEQRES 9 B 118 LEU TYR TRP GLY GLN GLY THR GLN VAL THR VAL SER SER SEQRES 10 B 118 HIS HET SO4 A 401 5 HET SO4 A 402 5 HET OLC A 403 25 HETNAM SO4 SULFATE ION HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 OLC C21 H40 O4 HELIX 1 AA1 SER A 120 SER A 141 1 22 HELIX 2 AA2 PHE A 142 LYS A 153 1 12 HELIX 3 AA3 SER A 159 VAL A 183 1 25 HELIX 4 AA4 VAL A 183 TYR A 194 1 12 HELIX 5 AA5 ASN A 202 TYR A 226 1 25 HELIX 6 AA6 SER A 234 VAL A 257 1 24 HELIX 7 AA7 THR A 261 TYR A 291 1 31 HELIX 8 AA8 SER A 298 ASN A 323 1 26 HELIX 9 AA9 ASP A 332 LEU A 356 1 25 HELIX 10 AB1 LYS B 88 THR B 92 5 5 SHEET 1 AA1 4 LEU A 26 THR A 27 0 SHEET 2 AA1 4 SER A 39 LEU A 46 -1 O THR A 45 N THR A 27 SHEET 3 AA1 4 SER A 85 SER A 91 -1 O PHE A 87 N VAL A 42 SHEET 4 AA1 4 LEU A 70 GLU A 71 -1 N GLU A 71 O THR A 90 SHEET 1 AA2 5 VAL A 31 LYS A 33 0 SHEET 2 AA2 5 ARG A 112 VAL A 117 1 O LEU A 116 N VAL A 32 SHEET 3 AA2 5 GLY A 95 HIS A 102 -1 N VAL A 99 O ILE A 113 SHEET 4 AA2 5 LEU A 54 ARG A 63 -1 N THR A 57 O HIS A 102 SHEET 5 AA2 5 VAL A 76 VAL A 78 -1 O VAL A 78 N LEU A 54 SHEET 1 AA3 6 LEU B 13 VAL B 14 0 SHEET 2 AA3 6 THR B 118 VAL B 122 1 O THR B 121 N VAL B 14 SHEET 3 AA3 6 ALA B 93 TYR B 101 -1 N TYR B 95 O THR B 118 SHEET 4 AA3 6 ASN B 34 GLN B 41 -1 N TYR B 39 O TYR B 96 SHEET 5 AA3 6 ARG B 47 ILE B 53 -1 O ALA B 51 N TRP B 38 SHEET 6 AA3 6 ASN B 60 TYR B 61 -1 O ASN B 60 N THR B 52 SHEET 1 AA4 3 LEU B 20 CYS B 24 0 SHEET 2 AA4 3 THR B 79 MET B 84 -1 O MET B 84 N LEU B 20 SHEET 3 AA4 3 PHE B 69 ASP B 74 -1 N ASP B 74 O THR B 79 SSBOND 1 CYS B 24 CYS B 97 1555 1555 2.04 CRYST1 49.510 71.270 194.640 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020198 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014031 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005138 0.00000